Abstract

The ATP-sensitive potassium (KATP) channel is a critical metabolic sensor in skeletal muscle, yet its definitive molecular composition and functional roles remain contested. In this study, I conclusively demonstrate that the Kir6.2/SUR2 complex forms sarcolemmal KATP channel in mouse fast-twitch muscle. Genetic knock-out (KO) of Kir6.2 (Kcnj11−/−) or SUR2 (Abcc9−/−) resulted in a similar phenotype with increased fatigue resistance and a pathological rise in unstimulated resting tension at high-frequency stimulation. In contrast, SUR1 (Abcc8−/−) KO was ineffective. Furthermore, a CRISPR/Cas9 knock-in mouse model of a human SUR2A truncation variant (KCGV/KCGV) recapitulated the abnormal force accumulation, demonstrating that even loss-of-function of this subunit specifically disrupts electromechanical stability. Crucially, the KV7 channel agonist retigabine (20 µM) partially prevented the increase in unstimulated tension, suggesting a potential therapeutic approach. I also have developed a same-day, suspension-mode fluorescence ion-flux assay that provides a greater than two-fold enhancement in signal intensity and can be used as a stable base for future high-throughput therapeutic screening. This would eliminate uncertainties in muscle KATP channel biology and create a pipeline from mechanistic discovery to potential therapeutic approach.

Committee Chair

Colin G. Nichols

Committee Members

Nathaniel Huebsch, Gretchen Meyer

Degree

Master of Science (MS)

Author's Department

Biomedical Engineering

Author's School

McKelvey School of Engineering

Document Type

Thesis

Date of Award

Fall 12-17-2025

Language

English (en)

Author's ORCID

https://orcid.org/0009-0004-0265-5067

Share

COinS